Aidoc Achieves FDA Clearance for Healthcare's First Comprehensive Foundation Model AI Triage Solution
核心洞察
Aidoc (搜索) secured FDA clearance for the healthcare industry's first comprehensive AI triage solution powered by its CARE (搜索) foundation model, combining 11 newly cleared indications with three existing ones for abdomen CT analysis.
The solution achieved exceptional performance metrics with 97% mean sensitivity and 98% mean specificity while delivering an order-of-magnitude reduction in false alerts compared to single-condition solutions.
The comprehensive triage system addresses critical challenges in Emergency Departments facing sustained pressure from rising patient volumes and imaging backlogs (搜索) by surfacing acute findings (搜索) earlier.
Aidoc (搜索) announced that the U.S. Food and Drug Administration has cleared the healthcare industry's first comprehensive AI triage solution, marking a significant breakthrough in clinical artificial intelligence. The solution, powered by Aidoc's proprietary CARE (搜索) foundation model, combines 11 newly cleared indications with three previously cleared indications into a single workflow for abdomen CT analysis.
Addressing Critical Healthcare Challenges
Emergency Departments face sustained pressure as patient volumes rise and imaging backlogs (搜索) grow, contributing to delays and crowding. With ED imaging typically read first-in, first-out, Aidoc (搜索)'s comprehensive triage approach provides a safety net that surfaces acute findings (搜索) earlier, supporting timely clinical decision-making and improving patient flow.
The same safety net extends to ambulatory settings, where unexpected critical findings can emerge from routine exams sitting in lengthy backlogs. By flagging these cases earlier, the solution helps reduce patient safety risk and supports timely follow-up.
Exceptional Performance Metrics
This clearance represents the first FDA approval of a comprehensive set of double-digit acute indications powered by a single foundation model. The solution delivers markedly improved signal quality, with roughly an order-of-magnitude reduction in false alerts compared to best-in-class, single-condition solutions.
In the FDA-reviewed pivotal study, the 11 indications achieved a mean sensitivity of 97% (up to 98.5%) and a mean specificity of 98% (up to 99.7%), enabling the safety, quality, and reliability required for real-world adoption.
Clinical Impact and Workflow Integration
"The ability to bring key acute conditions together into a single workflow is a fundamental shift in how radiology departments operate," said Heidi Beilis, MD, FACR, Chief Medical Officer of Diagnostics at WellSpan Health. "We've integrated numerous AI tools across our imaging operations, but this comprehensive triage solution can directly address core challenges in the field, including how we manage workflow, accelerating time-to-diagnosis for acute conditions and, ultimately, improving patient outcomes."
The comprehensive abdomen CT triage solution is delivered through Aidoc (搜索) aiOS (搜索), the company's enterprise AI operating system. aiOS sustains AI performance and impact at foundation-model scale through data normalization, continuous performance monitoring, and built-in governance, enabling health systems to deploy and manage multi-condition clinical AI without re-architecting infrastructure.
Proven Scale and Future Expansion
With more than 100 million patient cases analyzed, aiOS (搜索) is the most widely deployed clinical AI platform in healthcare. The solution has been designated as an FDA Breakthrough Device, underscoring its clinical significance and innovation potential.
"Health systems are increasingly looking to AI to improve access and tackle their most pressing priorities," said Elad Walach, CEO and co-founder of Aidoc (搜索). "With CARE (搜索), we knew breadth alone wasn't enough. We were committed to meeting the safety and quality threshold required for real-world clinical use. This FDA clearance, combining unprecedented breadth and accuracy, marks a new era for clinical AI, and we're excited to partner with physicians to improve patient care worldwide."
The CARE (搜索) solution roadmap is expected to expand to all CT and X-ray workflows over the next 18 months. Aidoc (搜索) is also developing capabilities such as automated draft report creation, advancing toward end-to-end clinical AI workflows.
Market Leadership
Aidoc (搜索) is a global leader in clinical AI, with the most FDA-cleared computer-aided detection solutions in the market. The company powers clinical decision-making for more than 60 million patients each year, with adoption across more than 1,600 medical centers worldwide, supporting health systems as they scale clinical AI responsibly and effectively.